Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.0085 | 0.8 |
mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | 0.013 | 0.8 |
mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.0085 | 0.8 |
mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.0083 | 0.8 |
mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.8 |
mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.0075 | 0.8 |
mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | -0.0073 | 0.8 |
mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.0077 | 0.8 |